Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF‑κB signaling pathway

Wan,Chun‑Xia; Xu,Man; Huang,Si‑Hui; Wu,Qing‑Qing; Yuan,Yuan; Deng,Wei; Tang,Qi‑Zhu

doi:10.3892/mmr.2017.8266

Baicalein protects against endothelial cell injury by inhibiting the TLR4/NF‑κB signaling pathway

Authors:
- Chun‑Xia Wan
- Man Xu
- Si‑Hui Huang
- Qing‑Qing Wu
- Yuan Yuan
- Wei Deng
- Qi‑Zhu Tang
View Affiliations

Affiliations: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, Hubei 430060, P.R. China
Published online on: December 12, 2017 https://doi.org/10.3892/mmr.2017.8266
Pages: 3085-3091
Copyright: © Wan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The involvement of vascular endothelial injury with the pathophysiological process of heart failure has been identified. Baicalein (BAI), a flavonoid extracted from the root of Scutellaria baicalensis, is reported to exert antibacterial, antiviral, antithrombotic and antioxidant effects. The aim of the present study was to investigate the effects of BAI on lipopolysaccharide (LPS)‑induced vascular endothelial injury. Human umbilical vein endothelial cells (HUVECs) were stimulated by LPS (10 µM) in the presence or absence of BAI. The expressions of the inflammatory cytokines interleukin (IL)‑lβ, IL‑6, tumor necrosis factor‑α (TNF‑α) and monocyte chemoattractant protein‑1 (MCP‑1) were analyzed by reverse transcription‑quantitative polymerase chain reaction, western blotting and enzyme‑linked immunosorbent assay. Cell apoptosis was assessed by flow cytometry and terminal deoxynucleotidyl transferase dUTP nick end labeling assay. The results showed that BAI significantly inhibited the LPS‑induced inflammatory response and apoptosis in HUVECs. BAI suppressed the LPS‑induced upregulation of IL‑1β, IL‑6, TNF‑α and MCP‑1. Furthermore, BAI decreased the expression of B‑cell lymphoma 2 (Bcl‑2)‑associated X protein and cleaved caspase‑3; however, it increased the protein level of Bcl‑2. The inhibitory effect of BAI may occur through the suppression of the Toll‑like receptor 4 (TLR4)/phosphorylated (p)‑transforming growth factor β‑activated kinase 1/tumor necrosis factor receptor‑associated family member associated nuclear factor (NF)‑κB activator‑binding kinase 1 (p‑TBK1)/NF‑κB signaling pathway. An increase in the level of p‑TBK1 by MRT67307 abolished the effect of BAI on p‑p65. In conclusion, the results of the present research suggested that BAI ameliorated endothelial cell injury associated with TLR4/NF‑κB signaling, and highlighted the potential clinical use of BAI in blocking endothelial dysfunction and preventing heart failure.

View Figures

View References

1	McCarron JG, Lee MD and Wilson C: The endothelium solves problems that endothelial cells do not know exist. Trends Pharmacol Sci. 38:322–338. 2017. View Article : Google Scholar : PubMed/NCBI
2	Fraisl P, Mazzone M, Schmidt T and Carmeliet P: Regulation of angiogenesis by oxygen and metabolism. Dev Cell. 16:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
3	Wei F, Liu S, Luo L, Gu N, Zeng Y, Chen X, Xu S and Zhang D: Anti-inflammatory mechanism of ulinastatin: Inhibiting the hyperpermeability of vascular endothelial cells induced by TNF-α via the RhoA/ROCK signal pathway. Int Immunopharmacol. 46:220–227. 2017. View Article : Google Scholar : PubMed/NCBI
4	Jang J, Jung Y, Kim Y, Jho EH and Yoon Y: LPS-induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974. Sci Rep. 7:416122017. View Article : Google Scholar : PubMed/NCBI
5	Yu X, Lan P, Hou X, Han Q, Lu N, Li T, Jiao C, Zhang J, Zhang C and Tian Z: HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production. J Hepatol. 66:693–702. 2017. View Article : Google Scholar : PubMed/NCBI
6	Peng T, Lu X, Lei M, Moe GW and Feng Q: Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia. Cardiovasc Res. 59:893–900. 2003. View Article : Google Scholar : PubMed/NCBI
7	Ives A, Nomura J, Martinon F, Roger T, LeRoy D, Miner JN, Simon G, Busso N and So A: Xanthine oxidoreductase regulates macrophage IL-1β secretion upon NLRP3 inflammasome activation. Nat Commun. 6:65552015. View Article : Google Scholar : PubMed/NCBI
8	Kim SD, Lee YJ, Baik JS, Han JY, Lee CG, Heo K, Park YS, Kim JS, Ji HD, Park SI, et al: Baicalein inhibits agonist- and tumor cell-induced platelet aggregation while suppressing pulmonary tumor metastasis via cAMP-mediated VASP phosphorylation along with impaired MAPKs and PI3K-Akt activation. Biochem Pharmacol. 92:251–265. 2014. View Article : Google Scholar : PubMed/NCBI
9	Wang Y, Han E, Xing Q, Yan J, Arrington A, Wang C, Tully D, Kowolik CM, Lu DM, Frankel PH, et al: Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells. Cancer Lett. 358:170–179. 2015. View Article : Google Scholar : PubMed/NCBI
10	Cai W, Fu Y, Zhang W, Chen X, Zhao J, Song W, Li Y, Huang Y, Wu Z, Sun R, et al: Synergistic effects of baicalein with cefotaxime against Klebsiella pneumoniae through inhibiting CTX-M-1 gene expression. BMC Microbiol. 16:1812016. View Article : Google Scholar : PubMed/NCBI
11	Tsai KL, Hung CH, Chan SH, Shih JY, Cheng YH, Tsai YJ, Lin HC and Chu PM: Baicalein protects against oxLDL-caused oxidative stress and inflammation by modulation of AMPK-alpha. Oncotarget. 7:72458–72468. 2016.PubMed/NCBI
12	Huang Y, Miao Z, Hu Y, Yuan Y, Zhou Y, Wei L, Zhao K, Guo Q and Lu N: Baicalein reduces angiogenesis in the inflammatory microenvironment via inhibiting the expression of AP-1. Oncotarget. 8:883–899. 2017.PubMed/NCBI
13	Zong J, Zhang DP, Zhou H, Bian ZY, Deng W, Dai J, Yuan Y, Gan HW, Guo HP and Tang QZ: Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling. J Cell Biochem. 114:1058–1065. 2013. View Article : Google Scholar : PubMed/NCBI
14	Zheng K, Setyawati MI, Lim TP, Leong DT and Xie J: Antimicrobial cluster bombs: Silver nanoclusters packed with daptomycin. ACS Nano. 10:7934–7942. 2016. View Article : Google Scholar : PubMed/NCBI
15	Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W and Schulte-Hermann R: In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology. 21:1465–1468. 1995. View Article : Google Scholar : PubMed/NCBI
16	Burchfield JS, Xie M and Hill JA: Pathological ventricular remodeling: Mechanisms: Part 1 of 2. Circulation. 128:388–400. 2013. View Article : Google Scholar : PubMed/NCBI
17	Heim A, Zeuke S, Weiss S, Ruschewski W and Grumbach IM: Transient induction of cytokine production in human myocardial fibroblasts by coxsackievirus B3. Circ Res. 86:753–759. 2000. View Article : Google Scholar : PubMed/NCBI
18	Pober JS and Sessa WC: Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 7:803–815. 2007. View Article : Google Scholar : PubMed/NCBI
19	Sahu BD, Mahesh Kumar J and Sistla R: Baicalein, a bioflavonoid, prevents cisplatin-induced acute kidney injury by up-regulating antioxidant defenses and down-regulating the MAPKs and NF-κB pathways. PLoS One. 10:e1341392015. View Article : Google Scholar
20	Chen S, Yang Y, Feng H, Wang H, Zhao R and Liu H: Baicalein inhibits interleukin-1-induced proliferation of human rheumatoid arthritis fibroblast-like synoviocytes. Inflammation. 37:163–169. 2014. View Article : Google Scholar : PubMed/NCBI
21	Wang CX, Xie GB, Zhou CH, Zhang XS, Li T, Xu JG, Li N, Ding K, Hang CH, Shi JX and Zhou ML: Baincalein alleviates early brain injury after experimental subarachnoid hemorrhage in rats: Possible involvement of TLR4/NF-κB-mediated inflammatory pathway. Brain Res. 1594:245–255. 2015. View Article : Google Scholar : PubMed/NCBI
22	Clark K, Peggie M, Plater L, Sorcek RJ, Young ER, Madwed JB, Hough J, McIver EG and Cohen P: Novel cross-talk within the IKK family controls innate immunity. Biochem J. 434:93–104. 2011. View Article : Google Scholar : PubMed/NCBI